RecruitingNot ApplicableNCT06821802

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis

Effect of Protein Supplementation in Hospitalized Patients With Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis - a Monocentric Randomized Open-label Pragmatic Active-controlled Trial - the TREASUREx Trial

Sponsor

University Hospital, Basel, Switzerland

Enrollment

70 participants

Start Date

Apr 14, 2025

Study Type

INTERVENTIONAL

Conditions

hyponatremia Syndrome of Inappropriate Antidiuresis

Summary

The goal of this study is to assess the impact of protein supplementation on hyponatremia caused by the syndrome of inappropriate antidiuresis during hospitalization.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Fluid restriction and Moltein PURE Protein Powder for people with syndrome of inappropriate antidiuresis and hyponatremia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTMoltein PURE Protein Powder

80 g protein supplementation per day (two bottles, each containing 40 g protein)

BEHAVIORALFluid restriction

total daily fluid intake to a maximum of 1000 ml

Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06821802

Related Trials

Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery

NCT072736301 location

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT044479116 locations

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

NCT064080771 location

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

NCT0602049512 locations